I ÐÍÉñ¾­ÏËάÁö²¡£¡£¡£¡£¡£¨NF1£©ÊÇÒ»ÖÖ³£È¾É«ÌåÏÔÐÔÒÅ´«ÐÔÖ×ÁöÐÔ¼²²¡£¬£¬£¬£¬£¬£¬£¬³£ÀÛ¼°¶àϵͳ¡£¡£¡£¡£¡£Ô¼ 30%-50% µÄ»¼Õß°é·¢´Ô×´Éñ¾­ÏËάÁö£¨PN£©£¬£¬£¬£¬£¬£¬£¬¿Éµ¼Ö»ÙÈÝ¡¢ÌÛÍ´¡¢ÉíÌ幦ЧÕÏ°­µÈÑÏÖØÎÊÌâ²¢ÏÔÖøÓ°Ï컼ÕßÉúÑÄÖÊÁ¿¡£¡£¡£¡£¡£PN »¼Õß´ó¶àÔÚÓ×ÄêʱÆÚÆ𲡣¬£¬£¬£¬£¬£¬£¬ÇÒÔÚÉú³¤·¢ÓýÒªº¦µÄ¶ùͯÆÚ¼²²¡Ï£Íû¸üΪѸËÙ£¬£¬£¬£¬£¬£¬£¬Òò´Ë¶ùͯ NF1-PN µÄÖÎÁÆÐèÇóÓÈΪÆÈÇв¡£¡£¡£¡£¡£

ÏÖÔÚÊÖÊõËäΪNF1Ïà¹ØPNµÄÖ÷ÒªÖÎÁÆÊֶΣ¬£¬£¬£¬£¬£¬£¬µ«ÓÉÓÚÁöÌåÆðÔ´ÓÚÉñ¾­£¬£¬£¬£¬£¬£¬£¬Ô¼Ö»ÓÐ15% µÄ»¼ÕßÖ×Áö¿ÉÍêÈ«Çгý£¬£¬£¬£¬£¬£¬£¬43%µÄ»¼ÕßÊõºó»á·ºÆðPN¸´·¢³¡£¡£¡£¡£¡£²»¿ÉÇгý»òÊõºó¸´·¢µÄ PN »¼ÕßÖÎÁÆÑ¡Ôñ¼«ÎªÓÐÏÞ£¬£¬£¬£¬£¬£¬£¬ÓÈÆäÊǹØÓÚ2 ËêµÄÖйú¶ùͯ»¼Õߣ¬£¬£¬£¬£¬£¬£¬ÔÚ«ÎÖÃÀÌæÄá»ñÅúÇ°ÎÞÒ©Îï¿ÉÓᣡ£¡£¡£¡£

±¾Ñо¿ÎªÒ»Ïî¶àÖÐÐÄ£¬£¬£¬£¬£¬£¬£¬¿ª·Å±êÇ©2ÆÚÁÙ´²ÊÔÑé¡£¡£¡£¡£¡£ÆäÖ÷ҪĿµÄÊÇÆÀ¹À«ÎÖÃÀÌæÄáƬ£¨FCN-159£©ÖÎÁƶùͯIÐÍÉñ¾­ÏËάÁö²¡Ïà¹Ø´Ô×´Éñ¾­ÏËάÁö£¨NF1Ïà¹ØPN£©µÄÓÐÓÃÐÔ¼°Çå¾²ÐÔ¡£¡£¡£¡£¡£Ö÷ÒªÖÕµãΪÑо¿ÕßÆÀ¹ÀµÄ¿Í¹Û»º½âÂÊ£¨ORR£©£¬£¬£¬£¬£¬£¬£¬Òªº¦´ÎÒªÖÕµãΪä̬×ÔÁ¦ÆÀÉóίԱ»á£¨BIRC£©ÆÀ¹ÀµÄORR¡£¡£¡£¡£¡£

×èÖ¹2024Äê9ÔÂ23ÈÕ£¬£¬£¬£¬£¬£¬£¬±¾Ïî¶àÖÐÐÄ£¬£¬£¬£¬£¬£¬£¬¿ª·Å±êÇ©2ÆÚÁÙ´²Ñо¿ÄÉÈë46Àý2-18Ë꣨²»º¬£©NF1Ïà¹ØPN¶ùͯ»¼Õß½ÓÊÜ«ÎÖÃÀÌæÄᣨ5 mg/m²£¬£¬£¬£¬£¬£¬£¬ÖðÈÕÒ»´Î£©ÖÎÁÆ¡£¡£¡£¡£¡£ÖÐλËæ·Ãʱ¼äΪ25.1¸öÔ¡£¡£¡£¡£¡£

ÔÚ43 Àý¿ÉÆÀ¹À»¼ÕßÖУ¬£¬£¬£¬£¬£¬£¬Ñо¿ÕßÆÀ¹ÀÇÒÈ·ÈϵĿ͹ۻº½âÂÊ£¨ORR£©´ï60.5%£¨95% CI£º44.4-75.0£©£¬£¬£¬£¬£¬£¬£¬26 ÀýµÖ´ï²¿·Ö»º½â£¨PR£©£¬£¬£¬£¬£¬£¬£¬17 Àý¼²²¡Îȹ̣¨SD£©£¬£¬£¬£¬£¬£¬£¬ÎÞ»¼Õß¼²²¡Ï£Íû¡£¡£¡£¡£¡£ÖÐλ»º½âÒ»Á¬Ê±¼ä£¨DOR£©ºÍÖÐλÎÞÏ£ÍûÉúÑÄÆÚ£¨PFS£©Î´µÖ´ï¡£¡£¡£¡£¡£

ÔÚ43Àý¿ÉÆÀ¹À»¼ÕßÖУ¬£¬£¬£¬£¬£¬£¬BIRCÆÀ¹ÀÇÒÈ·È쵀 ORR Ϊ44.2%£¨95% CI£º29.1-60.1£©£¬£¬£¬£¬£¬£¬£¬19 ÀýµÖ´ïPR£¬£¬£¬£¬£¬£¬£¬24 ÀýµÖ´ïSD£¬£¬£¬£¬£¬£¬£¬ÎÞ»¼Õß¼²²¡Ï£Íû¡£¡£¡£¡£¡£

Ñо¿ÕßÆÀ¹ÀµÄÖÐλÆðЧʱ¼äΪ4.7¸öÔ£¬£¬£¬£¬£¬£¬£¬BIRCÆÀ¹ÀµÄÖÐλÆðЧʱ¼äλ5.5¸öÔ¡£¡£¡£¡£¡£

ÔÚ 14 Àý¿ÉÆÀ¹ÀÌÛÍ´µÄ»¼ÕßÖУ¨¼´»ùÏß×ÜÌåÖ×ÁöÌÛÍ´ÆÀ·Ö¡Ý2ÇÒÖÁÉÙÓÐÒ»´Î»ùÏߺóÆÀ¹ÀµÄ»¼Õߣ©£¬£¬£¬£¬£¬£¬£¬Óë»ùÏßÏà±È£¬£¬£¬£¬£¬£¬£¬ÖÐλ×î´óÌÛÍ´½µµÍ·ÖÊýµÄת±äΪ-3.5·Ö¡£¡£¡£¡£¡£13Àý£¨92.9%£©»¼ÕßµÄÌÛÍ´ÆÀ·ÖÖÁÉÙ½µµÍ2·Ö£¬£¬£¬£¬£¬£¬£¬µÖ´ïÁËÁÙ´²ÒâÒåµÄ¸ÄÉÆ¡£¡£¡£¡£¡£11Àý£¨78.6%£©»¼ÕßµÄÌÛÍ´ÆÀ·ÖΪ0£¬£¬£¬£¬£¬£¬£¬¼´ÌÛÍ´ÍêÈ«ÏûÊÅ¡£¡£¡£¡£¡£

ÓëÑо¿Ò©ÎïÓйصIJ»Á¼ÊÂÎñ£¨TRAEs£©±¬·¢ÂÊΪ 97.8%£¬£¬£¬£¬£¬£¬£¬ÒÔ 1-2 ¼¶ÎªÖ÷£¬£¬£¬£¬£¬£¬£¬¡Ý3 ¼¶ TRAEs ½öÕ¼21.7%£¬£¬£¬£¬£¬£¬£¬³£¼û²»Á¼ÊÂÎñÖ÷Òª°üÀ¨¼×¹µÑ×£¨65.2%£©¡¢Ñª¼¡ËáÁ×Ëἤø£¨CPK£©Éý¸ß£¨56.5%£©¡¢¿ÚÇ»À£Ññ£¨52.2%£©ºÍѪÈéËáÍÑÇâøÉý¸ß£¨50%£©£¬£¬£¬£¬£¬£¬£¬¾ùΪ MEK ÒÖÖƼÁÀàÒ©Îï³£¼û¿É¿ØÐÔ·´Ó¦¡£¡£¡£¡£¡£

¸¹Í´¡¢¸¹Ðº¡¢¶ñÐĺÍÍÂÄæµÄ±¬·¢ÂÊÔÚ 2.2% ÖÁ 19.6% Ö®¼ä£¬£¬£¬£¬£¬£¬£¬ÇÒ¾ùδ´ï 3 ¼¶¡£¡£¡£¡£¡£½ö 2 Àý£¨4.3%£©»¼Õß·ºÆðÓëÑо¿Ò©ÎïÓйصÄÑÏÖز»Á¼ÊÂÎñ£¨ðî´¯ÑùƤÑ׺ÍѬȾÐÔ·ÎÑ×£©¡£¡£¡£¡£¡£13Àý£¨28.3%£©»¼Õß·ºÆðµ¼ÖÂÔÝÍ£ÓÃÒ©µÄTRAE£¬£¬£¬£¬£¬£¬£¬ÎÞTRAEµ¼Ö¼ÁÁ¿½µµÍ¡¢ÓÀÊÀÍ£Ò©»òéæÃü¡£¡£¡£¡£¡£»£»£»£»£»£»£»£»¼ÕßÒÀ´ÓÐÔµÖ´ï100%¡£¡£¡£¡£¡£

«ÎÖÃÀÌæÄáµÄÇå¾²ÐÔÓÅÒ죬£¬£¬£¬£¬£¬£¬²»Á¼ÊÂÎñ¾­ÓɶÔÖ¢ÖÎÁƺÍÔÝÍ£ÓÃÒ©ºó¿ÉÓÐÓÃÖÎÀí¡£¡£¡£¡£¡£ÔÚ¶ùͯ¼°ÇàÉÙÄêÖÐÄÍÊÜÐÔÓÅÒì¡£¡£¡£¡£¡£

×÷ΪÊ׸ö¹ú²úMEKÒÖÖƼÁ£¬£¬£¬£¬£¬£¬£¬Â«ÎÖÃÀÌæÄáÔڽṹÉÏͨ¹ýЭͬÉè¼Æ£¬£¬£¬£¬£¬£¬£¬ÊµÏÖÁË´úлÎȹ̡¢¸ßÑ¡ÔñÐԺ͵Ͷ¾ÐÔ£¬£¬£¬£¬£¬£¬£¬ÒÔ¼°°ëË¥ÆÚÑÓÉìµÄÓÅÊÆ¡£¡£¡£¡£¡£Ò©´ú¶¯Á¦Ñ§ÌØÕ÷Ö§³ÖÒ©ÎïÖðÈÕ¸øÒ©1´Î£¬£¬£¬£¬£¬£¬£¬²»ÊܲÍʳӰÏì²¢¾ßÓиüÉٵĺϲ¢ÓÃÒ©Ó°Ï죬£¬£¬£¬£¬£¬£¬¾ù´øÀ´¸üºÃµÄÒÀ´ÓÐÔ£¬£¬£¬£¬£¬£¬£¬Êʺ϶ùͯºã¾ÃÓÃÒ©¡£¡£¡£¡£¡£Â«ÎÖÃÀÌæÄá²»µ«ÒÔ¸ßÑ¡ÔñÐÔ»úÖÆÍ»ÆÆÁ˹ŰåÖÎÁƵľÖÏÞÐÔ£¬£¬£¬£¬£¬£¬£¬¸üͨ¹ýÏÔÖøµÄÖ×Áö»º½âÂÊÓëÌÛÍ´¸ÄÉÆÊý¾Ý£¬£¬£¬£¬£¬£¬£¬½«Îª NF1 »¼¶ù´øÀ´Æð¾¢µÄÁÙ´²»ñÒæ¡£¡£¡£¡£¡£

±ðµÄ£¬£¬£¬£¬£¬£¬£¬Â«ÎÖÃÀÌæÄáƬÓÃÓÚÖÎÁƳÉÈË¢ñÐÍÉñ¾­ÏËάÁö²¡ÓÚÖйú¾³ÄÚ´¦ÓÚ¢óÆÚÁÙ´²ÊÔÑé½×¶Î£¬£¬£¬£¬£¬£¬£¬¸ÃÒ©Æ·ÓÃÓÚ³õ¼¶±ðÄÔ½ºÖÊÁö¡¢Â­ÍâÐÂÎÅÂö»ûÐΡ¢¶ùͯÀʸñººË¹Ï¸°û×é֯ϸ°ûÔöÉúÖ¢µÄÖÎÁÆÓÚÖйú¾³ÄÚ¾ù´¦ÓÚ¢òÆÚÁÙ´²ÊÔÑé½×¶Î£¬£¬£¬£¬£¬£¬£¬ÆäÖУ¬£¬£¬£¬£¬£¬£¬¸ÃÒ©Æ·ÓÃÓÚÎÞ·¨ÊÖÊõ»òÊõºó²ÐÁô/¸´·¢µÄNF1Ïà¹ØµÄ´Ô×´Éñ¾­ÏËάÁö³ÉÈË»¼Õß¡¢¶ùͯÀʸñººË¹×é֯ϸ°ûÔöÉúÖ¢Á½Ïî˳Ӧ֢¾ùÒѱ»¹ú¼ÒÒ©¼à¾ÖÒ©Æ·ÉóÆÀÖÐÐÄÄÉÈëÍ»ÆÆÐÔÖÎÁÆÒ©Îï³ÌÐò¡£¡£¡£¡£¡£ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©½«Ò»Á¬Íƽø«ÎÖÃÀÌæÄáƬÔÚÆäËü˳Ӧ֢µÄ¿ª·¢£¬£¬£¬£¬£¬£¬£¬Îª¸ü¶à»¼Õß´øÀ´¸£Òô¡£¡£¡£¡£¡£

*ʵÖÊÁÏΪרҵҽѧ×ÊÁÏ£¬£¬£¬£¬£¬£¬£¬½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿²Î¿¼£¬£¬£¬£¬£¬£¬£¬ÏêϸÕïÁÆÐÅÏ¢Çë×ñÒ½Öö¡£¡£¡£¡£¡£

²Î¿¼ÎÄÏ×£º

1. JinHu Wang et al. JCO 43, 10044-10044(2025).

2. ÖйúÓÐÊý²¡Í¬ÃË¢ñÐÍÉñ¾­ÏËάÁö²¡¶àѧ¿ÆÕïÁÆЭ×÷×é. [J].ÓÐÊý²¡Ñо¿, 2023,2(2):210-230.

3. Fisher MJ, et al. Neuro Oncol. 2022;24(11):1827-1844